Stopping TKI Treatment Is Safe, Improves Quality of Life for Some with CML

SEMrush
For adults with CML who are in a sustained deep molecular remission, stopping treatment with a tyrosine kinase inhibitor is safe and improves their quality of life, a study shows. But researchers cautioned that these patients must be closely monitored.
[automaticbacklinks]